BACH1 and atopic eczema: Our validation of CBD as an BACH1 inhibitor suggests that CBD treatment would a) protect the skin against external insults: e.g. against UVA-irradiation-induced damage; and b) be greatly beneficial in a variety of skin conditions, e.g. eczema or atopic dermatitis.